Research Article
Expression of Killer Immunoglobulin Receptor Genes among HIV-Infected Individuals with Non-AIDS Comorbidities
Table 1
Demographic and clinical characteristics of study participants.
| | | % |
| Gender () | | | Male | 87 | 82.9 | Female | 18 | 17.1 | Age in years () | | | 25-44 | 42 | 40 | 45-59 | 44 | 41.9 | ≥ 60 | 19 | 18.1 | Sexual history () | | | Heterosexual | 54 | 52.9 | MSM | 33 | 32.4 | Bisexual | 14 | 13.7 | HIV route of transmission () | | | Unprotected sex | 72 | 68.6 | Shared needle/syringe | 7 | 6.7 | Others | 7 | 6.7 | Duration of HIV infection () | | | < 5 years | 9 | 10.3 | 5-10 years | 40 | 38.8 | > 10 years | 54 | 52.4 | Duration of cART () | | | < 5 years | 16 | 15.2 | 5-10 years | 42 | 40 | > 10 years | 47 | 44.8 | cART regimen () | | | NRTI + NNRTI | 47 | 46.1 | NRTI + INSTI | 47 | 46.1 | Others (PI + NRTI and/or NNRTI) | 8 | 7.8 | ≥ 1 non-AIDS associated comorbidities () | 44 | 41.9 | Hypertension | 31 | 29.5 | Hyperlipidemia | 31 | 29.5 | CVD | 10 | 9.5 | Diabetes | 9 | 8.6 | Non-cART medication () | | | Antihypertensives | 31 | 29.5 | Lipid-lowering agents | 31 | 29.5 | Hypoglycaemic agents | 9 | 8.6 |
|
|
MSM: men exclusively having sex with men; cART: combined antiretroviral therapy; NRTI: nucleoside/nucleotide reverse-transcriptase inhibitor; NNRTI: nonnucleoside reverse-transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor.
|